Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Ophthotech Nabs $175M To Fund Late-Stage Trial For Eye Drug 05/29/13 New York
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
VLST Raises $5M To Carry on With Autoimmune R&D 06/14/12 Seattle
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug 01/27/12 National
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team 01/23/12 Seattle
AlloCure Stem Cell Trial Provides Glimpse of Promising Treatment for Kidney Damage 11/18/11 Boston
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom 10/04/11 Seattle
Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News 08/31/11 Boston
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk 08/29/11 Boston
Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study 03/03/11 Boston
Calibra, Inspired by Inventor With Diabetes, Homes in on Cheap, Easy Way to Deliver Insulin 01/24/11 San Francisco
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug 01/21/11 San Diego
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
Institute for Systems Biology Makes it Official: It’s Moving to Seattle’s South Lake Union 08/18/10 Seattle
AlloCure, With Stem Cell Therapy for Kidney Failure, Arrives in New England with New CEO 07/06/10 Boston
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test 05/21/10 Seattle
Dendreon Makes History, Microsoft Tries Open-Source Biology, an OVP IPO Is Brewing, & More Seattle-Area Life Sciences News 05/06/10 Seattle
An OVP IPO is Brewing, Allozyne Doing Fine, VLST Finds Second Partner, & More Tidbits from the OVP Tech Summit 05/04/10 Seattle
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug 03/10/10 National
Page 1 of 2 next page »